Meeting
2012 Breast Cancer Symposium
Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
Authors
Elaine Walsh
Mater Misericordiae University Hospital
Elaine Walsh , Michael Farrell , Fergal Gallagher , Roisin Clarke , Carmel Nolan , M. Kennedy , Peter Daly , John McCaffrey , Elizabeth Connolly , Malcolm Kell , David Gallagher , Terence Boyle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Risk Assessment, Prevention, Detection, and Screening
Sub Track
High Risk
Citation
J Clin Oncol 30, 2012 (suppl 27; abstr 59)
DOI
10.1200/jco.2012.30.27_suppl.59
Abstract #
59
Poster Bd #
D20
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Impact of prior knowledge of mutation status on tumor stage in BRCA1/2 mutation carriers with newly diagnosed breast cancer.
First Author: Clinton Yam
Poster
2015 ASCO Annual Meeting
Oncotype-DX recurrence score distribution among breast cancer patients harboring a germline mutation in the BRCA1/2 genes.
First Author: Ron Lewin
Poster
2011 ASCO Annual Meeting
Long-term results of the Toronto magnetic resonance imaging (MRI) breast surveillance study of women with BRCA1 or BRCA2 mutations.
First Author: K. Passaperuma
Poster
2024 ASCO Genitourinary Cancers Symposium
SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline BRCA1/2 mutations.
First Author: Heather H. Cheng